← Leaderboards
Noel Weiss
Fred Hutchinson Cancer Research Center
$6,022,649
Attributed
$6,515,147
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $273.3K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,515,147 · 9
By mechanism
R01$2,429,211 · 3
T32$2,082,049 · 1
K05$1,462,225 · 1
R03$541,662 · 4
Top collaborators
- George Ioannou4 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Chu Chen$16,558,917
- Daniel W Lin$11,737,232
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCancer RiskHuman SubjectCessation Of LifePostmenopauseGenotypeIncidenceFemaleResearch PersonnelNeoplasm /Cancer DiagnosisMalignant Breast NeoplasmHuman Old Age (65+)Genetic PolymorphismHormonesFundingWomanDiagnosis Design /EvaluationHormone TherapyEpidemiologic StudiesNeoplasm /Cancer EpidemiologyAmericanMortality Vital StatisticsHealthcare SystemsDiagnosis Quality /Standard
Grant awards (34)
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$273,336
R01 · FY2018 · CA
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$273,336
R01 · FY2017 · CA
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$209,012
R01 · FY2016 · CA
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$229,312
R01 · FY2015 · CA
Mentoring and Research in Cancer Epidemiology$156,254
K05 · FY2013 · CA · contact PI
Mentoring and Research in Cancer Epidemiology$156,254
K05 · FY2012 · CA · contact PI
Mentoring and Research in Cancer Epidemiology$156,254
K05 · FY2011 · CA · contact PI
Mentoring and Research in Cancer Epidemiology$156,254
K05 · FY2010 · CA · contact PI
Combined hormone replacement therapy use in relation to breast cancer mortality.$63,000
R03 · FY2010 · CA · contact PI
Mentoring and Research in Cancer Epidemiology$156,254
K05 · FY2009 · CA · contact PI
Combined hormone replacement therapy use in relation to breast cancer mortality.$63,000
R03 · FY2009 · CA · contact PI
EST. INVESTIGATOR CAREER AWARD IN PREVENTION, CONTROL BEHAVIORAL & POPULATION RES$136,191
K05 · FY2006 · CA · contact PI
EST. INVESTIGATOR CAREER AWARD IN PREVENTION, CONTROL BEHAVIORAL &POPULATION RES$136,191
K05 · FY2005 · CA
Cancer Epidemiology and Biostatistics Training$414,637
T32 · FY2004 · CA
EST. INVESTIGATOR CAREER AWARD IN PREVENTION, CONTROL BEHAVIORAL &POPULATION RES$136,191
K05 · FY2004 · CA
Cancer Epidemiology and Biostatistics Training$32,296
T32 · FY2004 · CA
Cancer Epidemiology and Biostatistics Training$443,884
T32 · FY2003 · CA
Title Omitted$136,191
K05 · FY2003 · CA
Cancer Epidemiology and Biostatistics Training$31,600
T32 · FY2003 · CA
Cancer Epidemiology and Biostatistics Training$381,272
T32 · FY2002 · CA
IGF-I LEVELS, IGF-I GENOTYPE, AND PROSTATE CANCER$144,756
R01 · FY2002 · CA
Title Omitted$136,191
K05 · FY2002 · CA
Interval for colon cancer screening by sigmoidoscopy$86,500
R03 · FY2002 · CA
Androgen Pathway and Genetic Risk of Prostate Cancer$85,124
R03 · FY2002 · CA
Cancer Epidemiology and Biostatistics Training$29,470
T32 · FY2002 · CA
Cancer Epidemiology and Biostatistics Training$405,571
T32 · FY2001 · CA
IGF-I LEVELS, IGF-I GENOTYPE, AND PROSTATE CANCER$384,028
R01 · FY2001 · CA
ENDOMETRIAL CANCER AND POSTMENOPAUSAL HORMONE THERAPY$338,552
R01 · FY2001 · CA
Interval for colon cancer screening by sigmoidoscopy$86,500
R03 · FY2001 · CA
Androgen Pathway and Genetic Risk of Prostate Cancer$85,124
R03 · FY2001 · CA
ENDOMETRIAL CANCER AND POSTMENOPAUSAL HORMONE THERAPY$348,576
R01 · FY2000 · CA
CANCER EPIDEMTIOLOGY AND BIOSTATISTICS TRAINING$343,319
T32 · FY2000 · CA
IGF-I LEVELS, IGF-I GENOTYPE, AND PROSTATE CANCER$228,303
R01 · FY2000 · CA
CERVICAL CANCER SCREENING EFFICACY IN OLDER WOMEN$72,414
R03 · FY2000 · CA